Альманах-2013: новітні некоронарні кардіохірургічні втручання

P. Meier, O. Franzen, A.J. Lansky


Література

1. Abdel-Wahab M., Zahn R., Horack M. et al. Aortic regurgitation after transcatheter aortic valve implantation: incidence and early outcome. Results from the German transcatheter aortic valve interventions registry // Heart .. 2011.. 97.. P. 899.906.
2. Agnihotri A. 2012 ACCF/AATS/SCAI/STS expert consensus ocument on transcatheter aortic valve replacement: executive summary // J. Thorac. Cardiovasc. Surg.. 2012.. 144.. P. 534.537.
3. Alfieri O., Denti P. Alfieri stitch and its impact on mitral clip // Eur. J. Cardiothorac. Surg.. 2011.. 39.. P. 807.808.
4. Amat-Santos I.J., Dumont E., Villeneuve J. et al. Effect of thoracic epidural analgesia on clinical outcomes following transapical transcatheter aortic valve implantation // Heart.. 2012.. 98.. P. 1583.1590.
5. Astarci P., Glineur D., Kefer J. et al. Magnetic resonance imaging evaluation of cerebral embolization during percutaneous aortic valve implantation: comparison of transfemoral and trans-apical approaches using Edwards Sapiens valve // Eur. J. Cardiothorac. Surg.. 2011.. 40.. P. 475.479.
6. Bagur R., Manazzoni J.M., Dumont E. et al. Permanent pacemaker implantation following isolated aortic valve replacement in a large cohort of elderly patients with severe aortic stenosis // Heart.. 2011.. 97.. P. 1687.1694.
7. Bass J.L. Transcatheter occlusion of the left atrial appendage. experimental testing of a new Amplatzer device // Catheter Cardiovasc. Interv.. 2010.. 76.. P. 181.185.
8. Binder R.K., Webb J.G. TAVI: from home-made prosthesis to global interventional phenomenon // Heart.. 2012.. 98.. P. iv30.36.
9. Bourantas C.V., Farooq V., Onuma Y. et al. Transcatheter aortic valve implantation: new developments and upcoming clinical trials // EuroIntervention.. 2012.. 8.. P. 617.627.
10. Camm A.J., Lip G.Y., De Caterina R. et al. 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association // Eur. Heart J.. 2012.. 33.. P. 2719.2747.
11. Delgado V., Kapadia S., Marsan N.A. et al. Multimodality imaging before, during, and after percutaneous mitral valve repair // Heart.. 2011.. 97.. P. 1704.1714.
12. Dworakowski R., Wendler O., Bhan A. et al. Successful transcatheter aortic valve implantation (TAVI) is associated with transient left ventricular dysfunction // Heart.. 2012.. 98.. P. 1641.1646.
13. Dworakowski R., Wendler O. Optimal pain management after aortic valve implantation: an opportunity to improve outcomes after transapical access in the future? // Heart .. 2012.. 98.. P. 1541.1542.
14. Esler M.D., Krum H., Schlaich M. et al. Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial // Circulation.. 2012.. 126.. P. 2976.2982.
15. Esler M.D., Krum H., Sobotka P. A. et al. Renal sympathetic denervation in patients with treatment-resistant hypertension (the Symplicity HTN-2 trial): a randomized controlled trial // Lancet.. 2010.. 376.. P. 1903.1909.
16. European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, Camm A.J. et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC) // Eur. Heart J.. 2010.. 31.. P. 2369.2429.
17. Ewen S., Ukena C., Bohm M. et al. Percutaneous renal denervation: new treatment option for resistant hypertension and more? // Heart.. 2013.
18. Fairbairn T.A., Mather A.N., Bijsterveld P. et al. Diffusionweighted MRI determined cerebral embolic infarction following transcatheter aortic valve implantation: assessment of predictive risk factors and the relationship to subsequent health status // Heart.. 2012.. 98.. P. 18.23.
19. Feldman T., Foster E., Glower D.D. et al. Percutaneous repair or surgery for mitral regurgitation // New Engl. J. Med.. 2011.. 364.. P. 1395.1406.
20. Feldman T., Kar S., Rinaldi M. et al. Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort // J. Am. Coll. Cardiol.– 2009.– 54.– P. 686–694.
21. Feldman T., Wasserman H.S., Herrmann H.C. et al. Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST phase I clinical trial // J. Am. Coll. Cardiol.. 2005.. 46.. P. 2134.2140.
22. Fox B.D., Kahn S.R., Langleben D. et al. Efficacy and safety of novel oral anticoagulants for treatment of acute venous thromboembolism: direct and adjusted indirect meta-analysis of randomised controlled trials // BMJ.. 2012.. Vol. 345.. P. e7498.
23. Gaemperli O., Moccetti M., Surder D. et al. Acute haemodynamic changes after percutaneous mitral valve repair: relation to mid-term outcomes // Heart.. 2012.. 98.. P. 126.132.
24. Gallagher A.M., Rietbrock S., Plumb J. et al. Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis? // J. Thromb. Haemost.. 2008.. 6.. P. 1500.1506.
25. Garcia-Fernandez M.A., Perez-David E., Quiles J. et al. Role of left atrial appendage obliteration in stroke reduction in patients with mitral valve prosthesis: a transesophageal echocardiographic study // J. Am. Coll. Cardiol.. 2003.. Vol. 42.. P. 1253.1258.
26. Grant S.W., Devbhandari M.P., Grayson A.D. et al. What is the impact of providing a transcatheter aortic valve implantation service on conventional aortic valve surgical activity: patient risk factors and outcomes in the first 2 years // Heart.. 2010.. Vol. 96.. P. 1633.1637.
27. Gripari P., Ewe S.H., Fusini L. et al. Intraoperative 2D and 3D transoesophageal echocardiographic predictors of aortic regurgitation after transcatheter aortic valve implantation // Heart.. 2012.. 98.. P. 1229.1236.
28. Hahn R.T., Pibarot P., Stewart W.J. et al. Comparison of transcatheter and surgical aortic valve replacement in severe aortic stenosis: a longitudinal study of echo parameters in cohort A of the PARTNER trial // J. Am. Coll. Cardiol.. 2013.. 61.. P. 2514.2521.
29. Hering D., Mahfoud F., Walton A.S. et al. Renal denervation in moderate to severe CKD // J. Am. Soc. Nephrol.. 2012.. 23.. P. 1250.1257.
30. Holmes D.R., Reddy V.Y., Turi Z.G. et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial // Lancet.. 2009.. 374.. P. 534. 542.
31. Investigators S.H. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months // Hypertension.. 2011.. 57.. P. 911.917.
32. Iung B., Vahanian A. Degenerative calcific aortic stenosis: a natural history // Heart .. 2012.. 98.. P. iv7.13.
33. Kar S., Rinaldi M., Lim D.S. et al. EVEREST II REALISM: a continued access study to evaluate the safety and effectiveness of the MitraClip device: demographics and procedural outcomes. Society for Cardiovascular Angiography and Interventions (SCAI) 2011 Scientific Sessions; Baltimore, 2011.
34. Kempny A., Diller G..P., Kaleschke G. et al. Impact of transcatheter aortic valve implantation or surgical aortic valve replacement on right ventricular function // Heart.. 2012.. 35. Khattab A.A., Meier B. Transcatheter left atrial appendage exclusion, gold or foolЃfs gold? // Eur. Heart J.. 2010.. 12 (Suppl.). P. E35.40.
36. Krum H., Schlaich M., Whitbourn R. et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study // Lancet.. 2009.. 373.. P. 1275.1281.
37. Lloyd-Jones D.M., Wang T.J., Leip E.P. et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study // Circulation.. 2004.. 110.. P. 1042.1046.
38. Malaisrie S.C., Tuday E., Lapin B. et al. Transcatheter aortic valve implantation decreases the rate of unoperated aortic stenosis // Eur. J. Cardiothorac. Surg.. 2011.. 40.. P. 43.48.
39. Massumi A., Chelu M.G., Nazeri A. et al. Initial experience with a novel percutaneous left atrial appendage exclusion device in patients with atrial fibrillation, increased stroke risk, and contraindications to anticoagulation // Am. J. Cardiol.. 2013.. 111.. P. 869.873.
40. Meier P., Timmis A. Almanac 2012: interventional cardiology // Anadolu Kardiyol Derg.. 2012.. 13.. P. 91.101.
41. Meier P., Timmis A. Almanac 2012: interventional cardiology: the national society journals present selected research that has driven recent advances in clinical cardiology // Heart.. 2012.. 98.. P. 1701.1709.
42. MEMBERS W.C., Bonow R.O., Carabello B.A. et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons // Circulation.. 2008.. 118.. P. e523.661.
43. Mesa D., Castillo F., Ruiz Ortiz M. et al. Impact of transcatheter aortic valve implantation or surgical aortic valve replacement on right ventricular function // Heart.. 2013.. 99.. P. 286.
44. Munkholm-Larsen S., Cao C., Yan T.D. et al. Percutaneous atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: a systematic review // Heart.. 2012.. 98.. P. 900.907.
45. Mussardo M., Latib A., Chieffo A. et al. Periprocedural and short-term outcomes of transfemoral transcatheter aortic valve implantation with the Sapien XT as compared with the Edwards Sapien valve // JACC Cardiovasc. Interv.. 2011.. 4.. P. 743.750.
46. Naber C.K., Ghanem A., Abizaid A.A. et al. First-in-man use of a novel embolic protection device for patients undergoing transcatheter aortic valve implantation // EuroIntervention.. 2012.. 8.. P. 43.50.
47. Neragi-Miandoab S., Skripochnik E., Michler R.E. Recently patented and widely used valves for transcatheter aortic valve implantation // Recent Pat Cardiovasc. Drug Discov.. 2012.. 7.. P. 196.205.
48. Nietlispach F., Wijesinghe N., Gurvitch R. et al. An embolic deflection device for aortic valve interventions // JACC Cardiovasc. Interv.. 2010.. 3.. P. 1133.1138.
49. Nkomo V.T., Gardin J.M., Skelton T.N. et al. Burden of valvular heart diseases: a population-based study // Lancet.. 2006.. 368.. P. 1005.1011.
50. Onsea K., Agostoni P., Samim M. et al. First-in-man experience with a new embolic deflection device in transcatheter aortic valve interventions // EuroIntervention.. 2012.. 8.. P. 51.56.
51. Piazza N., Grube E., Gerckens U. et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval // EuroIntervention.. 2008.. 4.. P. 242.249.
52. Prendergast B.D., Naber C.K., Popma J.J. Transatlantic perspectives on TAVI: from essential infrastructure and integration to expansion, research and development // Heart.. 2012.. 98.. P. iv37.43.
53. Reddy V.Y., Doshi S.K., Sievert H. et al. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-year follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial // Circulation.. 2013.. 127.. P. 720.729.
54. Reddy V.Y., Holmes D., Doshi S.K. et al. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry // Circulation.. 2011.. 123.. P. 417.424.
55. Rinaldi M.J., Kar S., Lim D.S. et al. EVEREST II REALISM: a continued access study to evaluate the safety and effectiveness of the MitraClip device: analysis of a 6 month patient cohort. Society for Cardiovascular Angiography and Interventions (SCAI) 2011 Scientific Sessions; Baltimore, 2011.
56. Rosenhek R. Almanac 2011: valvular heart disease. The national society journals present selected research that has driven recent advances in clinical cardiology // Heart .. 2011.. 97.. P. 2007.2017.
57. Samad Z., Kaul P., Shaw L.K. et al. Impact of early surgery on survival of patients with severe mitral regurgitation // Heart.. 2011.. 97.. P. 221.224.
58. Sarkar K., Ussia G.P., Cammalleri V. et al. Quality of life of high risk patients following percutaneous mitral valve repair with the MitraClip system. Society for Cardiovascular Angiography and Interventions (SCAI) 2011 Scientific Sessions.. Baltimore, 2011.
59. Schofer J. REDUCE-HTN trial.. Paris: Euro PCR, 2013.
60. Sinning J..M., Werner N., Nickenig G. et al. Transcatheter aortic valve implantation: the evidence // Heart.. 2012.. 98.. P. iv65.72.
61. Sousa J.E., Costa M.A., Tuzcu E.M. et al. New frontiers in interventional cardiology // Circulation.. 2005.. 111.. P. 671.681.
62. Stortecky S., Buellesfeld L., Wenaweser P. et al. Transcatheter aortic valve implantation: the procedure // Heart.. 2012.. 98.. P. iv44.51.
63. Surder D., Pedrazzini G., Gaemperli O. et al. Predictors for efficacy of percutaneous mitral valve repair using the
MitraClip system: the results of the MitraSwiss registry // Heart.. 2013.. 99.. P. 1034.1040.
64. Svensson L.G., Tuzcu M., Kapadia S. et al. A comprehensive review of the PARTNER trial // J. Thorac. Cardiovasc. Surg.. 2013.. 145.. P. S11.16.
65. Tamburino C., Capodanno D., Ramondo A. et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis // Circulation.. 2011.. 123.. P. 299.308.
66. Tamburino C., Ussia G.P., Maisano F. et al. Percutaneous mitral valve repair with the MitraClip system: acute results from a real world setting // Eur. Heart J.. 2010.. 31.. P. 1382.1389.
67. Templin C., Jaguszewski M., Ghadri J.R. et al. Vascular lesions induced by renal nerve ablation as assessed by optical coherence tomography: pre- and post-procedural comparison with the Simplicity catheter system and the EnligHTN. multi-electrode renal denervation catheter // Eur. Heart J.. 2013 Apr 25. [Epub ahead of print] doi:10.1093/eurheartj/eht141
68. Thomas M., Schymik G., Walther T. et al. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve // Circulation.. 2011.. 124.. P. 425.343.
69. Thomas M., Schymik G., Walther T. et al. Thirty-day results of the SAPIEN aortic bioprosthesis European outcome (SOURCE) registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN Valve // Circulation.. 2010.. 122.. P. 62.69.
70. Viles-Gonzalez J.F., Kar S., Douglas P. et al. The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy // J. Am. Coll. Cardiol.. 2012.. 59.. P. 923.929.
71. Watt M., Mealing S., Eaton J. et al. Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement // Heart.. 2012.. 98.. P. 370.376.
72. Whitlow P.L., Feldman T., Pedersen W.R. et al. Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) high risk study // J. Am. Coll. Cardiol.. 2012.. 59.. P. 130.139.
73. Worthley S.G. EnligHTN-1: BP drops durable, safe at one year, as renal-denervation mania grows. EuroPCR.. Paris: Heartwire, 2013.

 

[PDF] [Зміст журналу]